The mission of the Georgetown University Memory Disorders Program is to prevent and treat Alzheimer's disease and related dementias by conducting innovative research, educating and training healthcare professionals and the public on research advances, and offering state-of-the-art clinical care.
MDP IN THE NEWS
The Nilotinib for Alzheimer's disease trial is now enrolling participants. Take a look at a recent interview with Dr. Turner and contact us for more information.
WE ARE ON FACEBOOK
"Like" our facebook page to stay up to date on research findings and helpful information
JOIN OUR MAILING LIST!
Would you like to receive our Fall newsletter? Sign up here to receive our newsletter either in the mail or via email. We send out two newsletters a year to everyone on our mailing list and as well invitations to our yearly fall appreciation event.
Research Studies
Here are our research studies that are currently recruiting patients.
| Title | Sponsor |
| Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4) | ATRI/ Eli Lilly and Company |
|
Biogen |
|
|
ATRI |
|
|
Georgetown University |
|
| Acadia | |
|
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) |
ATRI |
|
An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH) |
Eli Lilly & Co |
| Novartis | |
| ACRIN |
Check out our Research section for more information on how to participate in our clinical trials.
Make a Donation
For information about how to make a tax-deductible contribution to the Memory Disorders Program, please click here.